
BLAST2 result
BLASTP 2.2.2 [Dec-14-2001]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Query= TM0348.13
(381 letters)
Database: sprot
164,201 sequences; 59,974,054 total letters
Searching..................................................done
Score E
Sequences producing significant alignments: (bits) Value
PRTZ_HORVU (P06293) Protein Z (Z4) (Major endosperm albumin) 249 8e-66
SB10_HUMAN (P48595) Bomapin (Protease inhibitor 10) (Serpin B10) 147 6e-35
ANT3_MOUSE (P32261) Antithrombin-III precursor (ATIII) 141 3e-33
ANT3_SHEEP (P32262) Antithrombin-III precursor (ATIII) 140 5e-33
SCC2_HUMAN (P48594) Squamous cell carcinoma antigen 2 (SCCA-2) (... 139 2e-32
SCC1_HUMAN (P29508) Squamous cell carcinoma antigen 1 (SCCA-1) (... 138 2e-32
ANT3_BOVIN (P41361) Antithrombin-III (ATIII) 138 2e-32
ILEU_HUMAN (P30740) Leukocyte elastase inhibitor (LEI) (Monocyte... 134 5e-31
ANT3_HUMAN (P01008) Antithrombin-III precursor (ATIII) (PRO0309) 132 1e-30
PAI2_HUMAN (P05120) Plasminogen activator inhibitor-2 precursor ... 129 9e-30
ILEU_PIG (P80229) Leukocyte elastase inhibitor (LEI) (Leucocyte ... 129 9e-30
SB13_HUMAN (Q9UIV8) Hurpin (HaCaT UV-repressible serpin) (Protea... 128 3e-29
ILEU_HORSE (P05619) Leukocyte elastase inhibitor (LEI) 126 8e-29
PAI2_MOUSE (P12388) Plasminogen activator inhibitor-2, macrophag... 125 1e-28
SPB9_HUMAN (P50453) Cytoplasmic antiproteinase 3 (CAP3) (CAP-3) ... 124 4e-28
PAI2_RAT (P29524) Plasminogen activator inhibitor-2, type A (PAI... 122 2e-27
SB12_HUMAN (Q96P63) Serpin B12 121 3e-27
PTI6_HUMAN (P35237) Placental thrombin inhibitor (Cytoplasmic an... 121 3e-27
PTI6_MOUSE (Q60854) Placental thrombin inhibitor (Protease inhib... 117 5e-26
SPB8_HUMAN (P50452) Cytoplasmic antiproteinase 2 (CAP2) (CAP-2) ... 114 3e-25
>PRTZ_HORVU (P06293) Protein Z (Z4) (Major endosperm albumin)
Length = 399
Score = 249 bits (636), Expect = 8e-66
Identities = 137/303 (45%), Positives = 197/303 (64%), Gaps = 8/303 (2%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
++F NG+FVD S+SL F L QY A S+DF+++ + VNS +E + G I
Sbjct: 101 IAFANGIFVDASLSLKPSFEELAVCQYKAKTQSVDFQHKTLEAVGQVNSWVEQVTTGLIK 160
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGPRYEF-PFDLLNGTSVKVPFMTIKKKTH 196
Q+LPPG++ N T+LI NAL F+G W KFD + F LL+G+S++ FM+ KK
Sbjct: 161 QILPPGSVDNTTKLILGNALYFKGAWDQKFDESNTKCDSFHLLDGSSIQTQFMSSTKK-Q 219
Query: 197 YIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRRK 256
YI + D K+L+LPY +G D KR+FSM I LP A DGL +L +LS+EP F++ +P++
Sbjct: 220 YISSSDNLKVLKLPYAKGHD-KRQFSMYILLPGAQDGLWSLAKRLSTEPEFIENHIPKQT 278
Query: 257 VRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIFHK 316
V V Q+PKF IS+ FEAS++L+ +G+ PFS +A ++M++ S L + +FHK
Sbjct: 279 VEVGRFQLPKFKISYQFEASSLLRALGLQLPFSE-EADLSEMVD---SSQGLEISHVFHK 334
Query: 317 AFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVGQVL 376
+F+EVNE+GT+A AA+V V S +++F+ANHPFLFLIRED G ++FVG V
Sbjct: 335 SFVEVNEEGTEAGAATVAMG-VAMSMPLKVDLVDFVANHPFLFLIREDIAGVVVFVGHVT 393
Query: 377 NPL 379
NPL
Sbjct: 394 NPL 396
>SB10_HUMAN (P48595) Bomapin (Protease inhibitor 10) (Serpin B10)
Length = 397
Score = 147 bits (370), Expect = 6e-35
Identities = 99/307 (32%), Positives = 156/307 (50%), Gaps = 15/307 (4%)
Query: 74 DAHHLSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSN 133
D + L N ++ +K+ + + + + A ++F D++ D+NS +E Q+
Sbjct: 104 DDYLLKTANAIYGEKTYAFHNKYLEDMKTYFGAEPQPVNFVEASDQIRKDINSWVERQTE 163
Query: 134 GHITQLLPPGTITNLTRLIFANALRFQGLWKHKF-DGPRYEFPFDLLNGTSVKVPFMTIK 192
G I LLP ++ + TR+I NAL F+G+W+H+F E PF + TS V M +K
Sbjct: 164 GKIQNLLPDDSVDSTTRMILVNALYFKGIWEHQFLVQNTTEKPFRINETTSKPVQMMFMK 223
Query: 193 KKTHYIRAFDAFKI-LRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGK 251
KK H + L+L YK R S+ I LP+ +GL L ++ E
Sbjct: 224 KKLHIFHIEKPKAVGLQLYYK-----SRDLSLLILLPEDINGLEQLEKAITYEKLNEWTS 278
Query: 252 LPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVE 311
++ L +PKF + +++ + L +G+ FS A F+ M S + NL +
Sbjct: 279 ADMMELYEVQLHLPKFKLEDSYDLKSTLSSMGMSDAFSQSKADFSGM----SSARNLFLS 334
Query: 312 SIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILF 371
++FHKAF+E+NE+GT+A A S + R P I F ANHPFLF IR + T TILF
Sbjct: 335 NVFHKAFVEINEQGTEAAAGSGSEIDI----RIRVPSIEFNANHPFLFFIRHNKTNTILF 390
Query: 372 VGQVLNP 378
G++ +P
Sbjct: 391 YGRLCSP 397
>ANT3_MOUSE (P32261) Antithrombin-III precursor (ATIII)
Length = 465
Score = 141 bits (355), Expect = 3e-33
Identities = 97/299 (32%), Positives = 156/299 (51%), Gaps = 15/299 (5%)
Query: 82 NGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHITQLLP 141
N +F DKS++ + ++ + Y A L LDFK ++ +N+ + ++ G I ++P
Sbjct: 177 NRLFGDKSLTFNESYQDVSEVVYGAKLQPLDFKENPEQSRVTINNWVANKTEGRIKDVIP 236
Query: 142 PGTITNLTRLIFANALRFQGLWKHKF--DGPRYEFPFDLLNGTSVKVPFMTIKKKTHYIR 199
G I LT L+ N + F+GLWK KF + R E PF ++G S VP M + K Y R
Sbjct: 237 QGAINELTALVLVNTIYFKGLWKSKFSPENTRKE-PFYKVDGQSCPVPMMYQEGKFKYRR 295
Query: 200 AFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRRKVRV 259
+ ++L LP+K G D +M + LP L+ + +L+ P L+ L +
Sbjct: 296 VAEGTQVLELPFK-GDD----ITMVLILPKPEKSLAKVEQELT--PELLQEWLDELSETM 348
Query: 260 DALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIFHKAFI 319
+ +P+F F L+++G++ FSP + + + ++L V FHKAF+
Sbjct: 349 LVVHMPRFRTEDGFSLKEQLQDMGLIDLFSPEKSQLPGI--VAGGRDDLYVSDAFHKAFL 406
Query: 320 EVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVGQVLNP 378
EVNE+G++A A++ +T + P V F AN PFL LIRE TI+F+G+V NP
Sbjct: 407 EVNEEGSEAAAST--SVVITGRSLNPNRV-TFKANRPFLVLIREVALNTIIFMGRVANP 462
>ANT3_SHEEP (P32262) Antithrombin-III precursor (ATIII)
Length = 465
Score = 140 bits (353), Expect = 5e-33
Identities = 98/300 (32%), Positives = 154/300 (50%), Gaps = 17/300 (5%)
Query: 82 NGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHITQLLP 141
N +F DKS++ + ++ + Y A L LDFK ++ +N I ++ G IT ++P
Sbjct: 177 NRLFGDKSITFNETYQDISEVVYGAKLQPLDFKGNAEQSRLTINQWISNKTEGRITDVIP 236
Query: 142 PGTITNLTRLIFANALRFQGLWKHKF--DGPRYEFPFDLLNGTSVKVPFMTIKKKTHYIR 199
P I T L+ N + F+GLWK KF + + E F +G S VP M + K Y R
Sbjct: 237 PQAIDEFTVLVLVNTIYFKGLWKSKFSPENTKKEL-FYKADGESCSVPMMYQEGKFRYRR 295
Query: 200 AFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRRKVRV 259
+ ++L LP+K G D +M + LP L+ + +L+ P L+ L +
Sbjct: 296 VAEGTQVLELPFK-GDD----ITMVLILPKLEKPLAKVERELT--PDMLQEWLDELTETL 348
Query: 260 DALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIFHKAFI 319
+ +P F I +F L+++G+ FSP + + + N+L V FHKAF+
Sbjct: 349 LVVHMPHFRIEDSFSVKEQLQDMGLEDLFSPEKSRLPGI--VAEGRNDLYVSDAFHKAFL 406
Query: 320 EVNEKGTKATAASV-GFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVGQVLNP 378
EVNE+G++A A++V A + + R + F AN PFL LIRE TI+F+G+V NP
Sbjct: 407 EVNEEGSEAAASTVISIAGRSLNLNR----VTFQANRPFLVLIREVALNTIIFMGRVANP 462
>SCC2_HUMAN (P48594) Squamous cell carcinoma antigen 2 (SCCA-2)
(Leupin)
Length = 390
Score = 139 bits (349), Expect = 2e-32
Identities = 100/307 (32%), Positives = 151/307 (48%), Gaps = 15/307 (4%)
Query: 74 DAHHLSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSN 133
DA+ L N +F +K+ + + Y S+ S DF N + +NS +E Q+N
Sbjct: 97 DAYELKIANKLFGEKTYQFLQEYLDAIKKFYQTSVESTDFANAPEESRKKINSWVESQTN 156
Query: 134 GHITQLLPPGTITNLTRLIFANALRFQGLWKHKFDGPR-YEFPFDLLNGTSVKVPFMTIK 192
I L P GTI N T L+ NA+ F+G W++KF E F T V M
Sbjct: 157 EKIKNLFPDGTIGNDTTLVLVNAIYFKGQWENKFKKENTKEEKFWPNKNTYKSVQMMRQY 216
Query: 193 KKTHYIRAFDA-FKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGK 251
++ D K+L +PYK G+D SM + LP+ DGL L KL++E
Sbjct: 217 NSFNFALLEDVQAKVLEIPYK-GKD----LSMIVLLPNEIDGLQKLEEKLTAEKLMEWTS 271
Query: 252 LPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVE 311
L + L +P+F + +++ + L+ +G+V+ F+ DA + M + S+ L V
Sbjct: 272 LQNMRETCVDLHLPRFKMEESYDLKDTLRTMGMVNIFNG-DADLSGM----TWSHGLSVS 326
Query: 312 SIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILF 371
+ HKAF+EV E+G +A AA+ A V P F NHPFLF IR++ T +ILF
Sbjct: 327 KVLHKAFVEVTEEGVEAAAAT---AVVVVELSSPSTNEEFCCNHPFLFFIRQNKTNSILF 383
Query: 372 VGQVLNP 378
G+ +P
Sbjct: 384 YGRFSSP 390
>SCC1_HUMAN (P29508) Squamous cell carcinoma antigen 1 (SCCA-1)
(Protein T4-A)
Length = 390
Score = 138 bits (348), Expect = 2e-32
Identities = 102/310 (32%), Positives = 155/310 (49%), Gaps = 21/310 (6%)
Query: 74 DAHHLSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSN 133
DA+ L N +F +K+ + + Y S+ S+DF N + +NS +E Q+N
Sbjct: 97 DAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTN 156
Query: 134 GHITQLLPPGTITNLTRLIFANALRFQGLWKHKFD-GPRYEFPFDLLNGTSVKVPFMTIK 192
I L+P G I + T L+ NA+ F+G W+ KF+ E F T + M
Sbjct: 157 EKIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQY 216
Query: 193 KKTHYIRAFDA-FKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGK 251
H+ D K+L +PYK G+D SM + LP+ DGL L KL++E
Sbjct: 217 TSFHFASLEDVQAKVLEIPYK-GKD----LSMIVLLPNEIDGLQKLEEKLTAEKLMEWTS 271
Query: 252 LPR-RKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
L R+ RVD L +P+F + +++ + L+ +G+V F+ DA + M + S L +
Sbjct: 272 LQNMRETRVD-LHLPRFKVEESYDLKDTLRTMGMVDIFNG-DADLSGM----TGSRGLVL 325
Query: 311 ESIFHKAFIEVNEKGTKATAAS--VGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGT 368
+ HKAF+EV E+G +A AA+ VGF S F NHPFLF IR++ T +
Sbjct: 326 SGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTSTNE-----EFHCNHPFLFFIRQNKTNS 380
Query: 369 ILFVGQVLNP 378
ILF G+ +P
Sbjct: 381 ILFYGRFSSP 390
>ANT3_BOVIN (P41361) Antithrombin-III (ATIII)
Length = 433
Score = 138 bits (348), Expect = 2e-32
Identities = 97/300 (32%), Positives = 156/300 (51%), Gaps = 17/300 (5%)
Query: 82 NGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHITQLLP 141
N +F DKS++ + ++ + Y A L LDFK ++ +N I ++ G IT ++P
Sbjct: 145 NRLFGDKSITFNETYQDISEVVYGAKLQPLDFKGNAEQSRLTINQWISNKTEGRITDVIP 204
Query: 142 PGTITNLTRLIFANALRFQGLWKHKF--DGPRYEFPFDLLNGTSVKVPFMTIKKKTHYIR 199
P I T L+ N + F+GLWK KF + R E F +G S V M + K Y R
Sbjct: 205 PQAINEFTVLVLVNTIYFKGLWKSKFSPENTRKEL-FYKADGESCSVLMMYQESKFRYRR 263
Query: 200 AFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRRKVRV 259
++ ++L LP+K G D +M + LP L+ + +L+ P L+ L +
Sbjct: 264 VAESTQVLELPFK-GDD----ITMVLILPKLEKTLAKVEQELT--PDMLQEWLDELTETL 316
Query: 260 DALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIFHKAFI 319
+ +P+F I +F L+++G+ FSP + + + ++L V FHKAF+
Sbjct: 317 LVVHMPRFRIEDSFSVKEQLQDMGLEDLFSPEKSRLPGI--VAEGRSDLYVSDAFHKAFL 374
Query: 320 EVNEKGTKATAASV-GFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVGQVLNP 378
EVNE+G++A A++V A + ++ R + F AN PFL LIRE TI+F+G+V NP
Sbjct: 375 EVNEEGSEAAASTVISIAGRSLNSDR----VTFKANRPFLVLIREVALNTIIFMGRVANP 430
>ILEU_HUMAN (P30740) Leukocyte elastase inhibitor (LEI)
(Monocyte/neutrophil elastase inhibitor) (M/NEI) (EI)
Length = 379
Score = 134 bits (336), Expect = 5e-31
Identities = 96/307 (31%), Positives = 154/307 (49%), Gaps = 19/307 (6%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N ++ +K+ + F + Y A LAS+DF++ + +N ++ Q+ G I
Sbjct: 86 LKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIP 145
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKF-DGPRYEFPFDLLNGTSVKVPFMTIKKKTH 196
+LL G + N+T+L+ NA+ F+G WK KF PF L V M KKK
Sbjct: 146 ELLASGMVDNMTKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFA 205
Query: 197 YIRAFD-AFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRR 255
Y D ++L LPY QG + SM I LPD + S + K+ + K +
Sbjct: 206 YGYIEDLKCRVLELPY-QGEE----LSMVILLPDDIEDESTGLKKIEEQLTLEKLHEWTK 260
Query: 256 KVRVDALQI----PKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVE 311
+D +++ P+F + ++ ++ L +GV F+ A + M S + ++ +
Sbjct: 261 PENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGM----SGARDIFIS 316
Query: 312 SIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILF 371
I HK+F+EVNE+GT+A AA+ G A P NF A+HPFLF IR + +G+ILF
Sbjct: 317 KIVHKSFVEVNEEGTEAAAATAGIATFCMLM----PEENFTADHPFLFFIRHNSSGSILF 372
Query: 372 VGQVLNP 378
+G+ +P
Sbjct: 373 LGRFSSP 379
>ANT3_HUMAN (P01008) Antithrombin-III precursor (ATIII) (PRO0309)
Length = 464
Score = 132 bits (333), Expect = 1e-30
Identities = 95/300 (31%), Positives = 152/300 (50%), Gaps = 17/300 (5%)
Query: 82 NGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHITQLLP 141
N +F DKS++ + ++ + Y A L LDFK ++ +N + ++ G IT ++P
Sbjct: 176 NRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIP 235
Query: 142 PGTITNLTRLIFANALRFQGLWKHKF--DGPRYEFPFDLLNGTSVKVPFMTIKKKTHYIR 199
I LT L+ N + F+GLWK KF + R E F +G S M + K Y R
Sbjct: 236 SEAINELTVLVLVNTIYFKGLWKSKFSPENTRKEL-FYKADGESCSASMMYQEGKFRYRR 294
Query: 200 AFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPRRKVRV 259
+ ++L LP+K G D +M + LP L+ + +L+ P L+ L + +
Sbjct: 295 VAEGTQVLELPFK-GDD----ITMVLILPKPEKSLAKVEKELT--PEVLQEWLDELEEMM 347
Query: 260 DALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIFHKAFI 319
+ +P+F I F L+++G+V FSP + + + ++L V FHKAF+
Sbjct: 348 LVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGI--VAEGRDDLYVSDAFHKAFL 405
Query: 320 EVNEKGTKATAASVGFAPVTQSARRPGP-VINFIANHPFLFLIREDFTGTILFVGQVLNP 378
EVNE+G++A A++ V + R P + F AN PFL IRE TI+F+G+V NP
Sbjct: 406 EVNEEGSEAAASTA----VVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANP 461
>PAI2_HUMAN (P05120) Plasminogen activator inhibitor-2 precursor
(PAI-2) (Placental plasminogen activator inhibitor)
(Monocyte Arg-serpin) (Urokinase inhibitor)
Length = 415
Score = 129 bits (325), Expect = 9e-30
Identities = 96/311 (30%), Positives = 151/311 (47%), Gaps = 28/311 (9%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +KS S + L Y++ ++DF + +NS ++ Q+ G I
Sbjct: 123 LESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIP 182
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFD---GPRYEFPFDLLNGTSVKVPFMTIKKK 194
LLP G++ TR++ NA+ F+G WK F+ Y F + T V++ ++ K
Sbjct: 183 NLLPEGSVDGDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLN 242
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGF------- 247
YI A +IL LPY SM + LPD +S + L SE +
Sbjct: 243 IGYIEDLKA-QILELPYAGD------VSMFLLLPDEIADVSTGLELLESEITYDKLNKWT 295
Query: 248 LKGKLPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNN 307
K K+ +V V IP+F + +E ++L+ +G+ F+ A F+ M S N+
Sbjct: 296 SKDKMAEDEVEV---YIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGM----SERND 348
Query: 308 LCVESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTG 367
L + +FH+A ++VNE+GT+A A + G +T GP F+A+HPFLFLI T
Sbjct: 349 LFLSEVFHQAMVDVNEEGTEAAAGTGGV--MTGRTGHGGP--QFVADHPFLFLIMHKITN 404
Query: 368 TILFVGQVLNP 378
ILF G+ +P
Sbjct: 405 CILFFGRFSSP 415
>ILEU_PIG (P80229) Leukocyte elastase inhibitor (LEI) (Leucocyte
neutral proteinase inhibitor) (LNPI)
Length = 378
Score = 129 bits (325), Expect = 9e-30
Identities = 97/308 (31%), Positives = 152/308 (48%), Gaps = 22/308 (7%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +K+ F Y A LAS+DF + +N ++ Q+ G I
Sbjct: 86 LKLANRLFGEKTYHFLPEFLASTQKTYGAELASVDFLRASEEARKAINEWVKEQTEGKIP 145
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKF-DGPRYEFPFDLLNGTSVKVPFMTIKKK-- 194
+LL G + + T+L+ NA+ F+G W+ KF + PF L S V M KKK
Sbjct: 146 ELLASGVVDSATKLVLVNAIYFKGSWQEKFMTEATKDAPFRLNKKDSKTVKMMYQKKKFP 205
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPR 254
YI+ ++L LPY QG+D SM I LPD+ + S + K+ K
Sbjct: 206 FGYIKELKC-RVLELPY-QGKD----LSMVILLPDSIEDESTGLRKIEQHLTLEKLNEWT 259
Query: 255 RKVRVDALQI----PKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
+ ++ L++ P+F + +++ + L +GV F A T M S + +L +
Sbjct: 260 KPDNLELLEVNVHLPRFRLEESYDLNAPLARLGVQDLFGSR-ADLTGM----SEARDLFI 314
Query: 311 ESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTIL 370
+ HKAF+EVNE+GT+A AA+ G A P +FIA+HPF+F IR + + IL
Sbjct: 315 SKVVHKAFVEVNEEGTEAAAATAGIAVFAMLM----PEEDFIADHPFIFFIRHNPSSNIL 370
Query: 371 FVGQVLNP 378
F+G++ +P
Sbjct: 371 FLGRLSSP 378
>SB13_HUMAN (Q9UIV8) Hurpin (HaCaT UV-repressible serpin) (Protease
inhibitor 13) (Headpin) (Serpin B13)
Length = 391
Score = 128 bits (321), Expect = 3e-29
Identities = 94/309 (30%), Positives = 147/309 (47%), Gaps = 23/309 (7%)
Query: 76 HHLSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGH 135
+ L+ TN +F +K+ + + Y+ASL +DF N D +NS +E ++N
Sbjct: 100 YELNITNRLFGEKTYLFLQKYLDYVEKYYHASLEPVDFVNAADESRKKINSWVESKTNEK 159
Query: 136 ITQLLPPGTITNLTRLIFANALRFQGLWKHKFDGPR-YEFPFDLLNGTSVKVPFMTIKKK 194
I L P G+I++ T+L+ N + F+G W +F E F + TS V MT
Sbjct: 160 IKDLFPDGSISSSTKLVLVNMVYFKGQWDREFKKENTKEEKFWMNKSTSKSVQMMTQSHS 219
Query: 195 THYIRAFD-AFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSE---PGFLKG 250
+ D KIL +PYK SM + LP+ DGL ++ K+S E G
Sbjct: 220 FSFTFLEDLQAKILGIPYK-----NNDLSMFVLLPNDIDGLEKIIDKISPEKLVEWTSPG 274
Query: 251 KLPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
+ RKV L +P+F + ++ VL +G+ FS A ++ M S + L
Sbjct: 275 HMEERKVN---LHLPRFEVEDGYDLEAVLAAMGMGDAFSEHKADYSGM----SSGSGLYA 327
Query: 311 ESIFHKAFIEVNEKGTKATAAS-VGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTI 369
+ H +F+ V E+GT+A AA+ +GF + N NHPFLF IR + + +I
Sbjct: 328 QKFLHSSFVAVTEEGTEAAAATGIGFTVTSAPGHE-----NVHCNHPFLFFIRHNESNSI 382
Query: 370 LFVGQVLNP 378
LF G+ +P
Sbjct: 383 LFFGRFSSP 391
>ILEU_HORSE (P05619) Leukocyte elastase inhibitor (LEI)
Length = 379
Score = 126 bits (317), Expect = 8e-29
Identities = 94/307 (30%), Positives = 154/307 (49%), Gaps = 19/307 (6%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N ++ +K+ + F Y A LAS+DF+ + ++N ++ Q+ G I
Sbjct: 86 LKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIP 145
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKF-DGPRYEFPFDLLNGTSVKVPFMTIKKKTH 196
+LL G + N+T+L+ NA+ F+G W+ KF + PF L + V M KKK
Sbjct: 146 ELLVKGMVDNMTKLVLVNAIYFKGNWQEKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFP 205
Query: 197 YIRAFD-AFKILRLPYKQGRDRKRRFSMCIFLP----DASDGLSALVHKLSSEPGFLKGK 251
Y D ++L LPY QG++ SM I LP D S GL + +L+ E K
Sbjct: 206 YNYIEDLKCRVLELPY-QGKE----LSMIILLPDDIEDESTGLEKIEKQLTLEKLREWTK 260
Query: 252 LPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVE 311
+ + +P+F + +++ ++ L +GV F+ A + M S + +L V
Sbjct: 261 PENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRGKADLSGM----SGARDLFVS 316
Query: 312 SIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILF 371
I HK+F+++NE+GT+A AA+ G + P NF A+HPF+F IR + + ILF
Sbjct: 317 KIIHKSFVDLNEEGTEAAAATAGTIMLAMLM----PEENFNADHPFIFFIRHNPSANILF 372
Query: 372 VGQVLNP 378
+G+ +P
Sbjct: 373 LGRFSSP 379
>PAI2_MOUSE (P12388) Plasminogen activator inhibitor-2, macrophage
(PAI-2)
Length = 415
Score = 125 bits (315), Expect = 1e-28
Identities = 93/308 (30%), Positives = 148/308 (47%), Gaps = 22/308 (7%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +KS + L Y+ ++DF + +NS ++ Q+ G I
Sbjct: 123 LESANKLFGEKSARFKEEYIQLSKKYYSTEPEAVDFLECAEEAREKINSWVKTQTKGEIP 182
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFD---GPRYEFPFDLLNGTSVKVPFMTIKKK 194
LLP G++ T+++ NA+ F+G WK F+ Y F + V++ F+ K
Sbjct: 183 NLLPEGSVDEDTKMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSHESIPVQMMFLHAKLN 242
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPR 254
YI+ +IL LP+ SM + LPD + S + L SE F
Sbjct: 243 IGYIKDLKT-QILELPH------TGNISMLLLLPDEIEDASTGLELLESEINFANFNKWI 295
Query: 255 RKVRVD----ALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
K +D + IPKF ++ ++E ++L+ +G+ F+ A F+ M S N+L +
Sbjct: 296 SKDTLDEDDVVVYIPKFKLAQSYELKSILQSMGMEDAFNKGKANFSGM----SERNDLFL 351
Query: 311 ESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTIL 370
+FH+A ++V E+GT A A G A +T GP F+A+HPFLF I + T TIL
Sbjct: 352 SEVFHQASVDVTEEGTVA-AGGTG-AVMTGRTGHGGP--QFVADHPFLFFIMDKITHTIL 407
Query: 371 FVGQVLNP 378
FVG+ +P
Sbjct: 408 FVGRFSSP 415
>SPB9_HUMAN (P50453) Cytoplasmic antiproteinase 3 (CAP3) (CAP-3)
(Protease inhibitor 9) (Serpin B9)
Length = 376
Score = 124 bits (311), Expect = 4e-28
Identities = 91/304 (29%), Positives = 143/304 (46%), Gaps = 16/304 (5%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +K+ F+ Y+A L L F + +N+ + ++ G I
Sbjct: 86 LRTANRLFGEKTCQFLSTFKESCLQFYHAELKELSFIRAAEESRKHINTWVSKKTEGKIE 145
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGP-RYEFPFDLLNGTS--VKVPFMTIKKK 194
+LLP +I TRL+ NA+ F+G W FD E PF + V++ + K
Sbjct: 146 ELLPGSSIDAETRLVLVNAIYFKGKWNEPFDETYTREMPFKINQEEQRPVQMMYQEATFK 205
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPR 254
++ A ++L LPY ++ S+ + LPD LS + L+ E K
Sbjct: 206 LAHVGEVRA-QLLELPY-----ARKELSLLVLLPDDGVELSTVEKSLTFEKLTAWTKPDC 259
Query: 255 RKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESIF 314
K + +PKF + ++ +VL+ +G+V F A + M S +LC+
Sbjct: 260 MKSTEVEVLLPKFKLQEDYDMESVLRHLGIVDAFQQGKADLSAM----SAERDLCLSKFV 315
Query: 315 HKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVGQ 374
HK+F+EVNE+GT+A AAS F V + GP F A+HPFLF IR + +ILF G+
Sbjct: 316 HKSFVEVNEEGTEAAAASSCFV-VAECCMESGP--RFCADHPFLFFIRHNRANSILFCGR 372
Query: 375 VLNP 378
+P
Sbjct: 373 FSSP 376
>PAI2_RAT (P29524) Plasminogen activator inhibitor-2, type A (PAI2A)
(PAI-2)
Length = 416
Score = 122 bits (306), Expect = 2e-27
Identities = 93/308 (30%), Positives = 145/308 (46%), Gaps = 22/308 (7%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +KS + Y+ ++DF + +NS ++ Q+ G I
Sbjct: 124 LESANKLFGEKSARFKEEYIQRCKKYYSTEPEAVDFLECANEARKKINSWVKTQTKGEIP 183
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFD---GPRYEFPFDLLNGTSVKVPFMTIKKK 194
LLP G++ T+++ N + F+G WK F Y F +L V++ ++ K
Sbjct: 184 NLLPEGSVDEDTKMVLVNTIYFKGRWKTPFQKRLNGLYPFRVNLNESKPVQMMYLREKLN 243
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLPR 254
YI+ +IL LPY SM + LPD + S + L E F
Sbjct: 244 IGYIKDLKT-QILELPY------IGNISMFLLLPDEIEDSSTGLEMLEREINFDNFNKWI 296
Query: 255 RKVRVD----ALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
K +D + IPKF ++ +E +L+ +G+ F+ A F+ M S SN+L +
Sbjct: 297 SKETLDEDDVLVYIPKFKLAQNYELKPILQRMGMEDAFNKGKADFSGM----SESNDLFL 352
Query: 311 ESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTIL 370
+FH+A ++VNE+GT A A G A +T GP F+A+HPFLF I + T TIL
Sbjct: 353 SEVFHQATVDVNEEGTVA-AGGTG-AVMTGRTGHGGP--QFVADHPFLFFIMNNITRTIL 408
Query: 371 FVGQVLNP 378
FVG+ +P
Sbjct: 409 FVGRFSSP 416
>SB12_HUMAN (Q96P63) Serpin B12
Length = 405
Score = 121 bits (303), Expect = 3e-27
Identities = 92/308 (29%), Positives = 150/308 (47%), Gaps = 21/308 (6%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
LS N ++ ++ + + + Y+ ++ S+DF+ ++ ++N +E QS G I
Sbjct: 112 LSIANRLYGEQEFPICQEYLDGVIQFYHTTIESVDFQKNPEKSRQEINFWVECQSQGKIK 171
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGPR-YEFPFDLLNGTSVKVPFMTIK--KK 194
+L I T L+ NA+ F+ W+ FD + PF L + V MT K +
Sbjct: 172 ELFSKDAINAETVLVLVNAVYFKAKWETYFDHENTVDAPFCLNANENKSVKMMTQKGLYR 231
Query: 195 THYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLP----DASDGLSALVHKLSSEPGFLKG 250
+I A +IL + Y +G + SM + LP D GL L K++ E
Sbjct: 232 IGFIEEVKA-QILEMRYTKG-----KLSMFVLLPSHSKDNLKGLEELERKITYEKMVAWS 285
Query: 251 KLPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCV 310
L P+F + +++ +++L+++G+ F A T + SPS NL +
Sbjct: 286 SSENMSEESVVLSFPRFTLEDSYDLNSILQDMGITDIFDETRADLTGI----SPSPNLYL 341
Query: 311 ESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTIL 370
I HK F+EV+E GT+A AA+ A V++ + R + F ANHPFLF IR + T TIL
Sbjct: 342 SKIIHKTFVEVDENGTQAAAAT--GAVVSERSLRSW--VEFNANHPFLFFIRHNKTQTIL 397
Query: 371 FVGQVLNP 378
F G+V +P
Sbjct: 398 FYGRVCSP 405
>PTI6_HUMAN (P35237) Placental thrombin inhibitor (Cytoplasmic
antiproteinase) (CAP) (Protease inhibitor 6) (PI-6)
Length = 376
Score = 121 bits (303), Expect = 3e-27
Identities = 91/305 (29%), Positives = 147/305 (47%), Gaps = 20/305 (6%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +KS FR Y A + LDF + ++ +N+ + ++ G I
Sbjct: 88 LRVANRLFGEKSCDFLSSFRDSCQKFYQAEMEELDFISAVEKSRKHINTWVAEKTEGKIA 147
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGPRYEFPFDLLNGTSVKVPFMTIK----K 193
+LL PG++ LTRL+ NA+ F+G W +FD E ++ K M K K
Sbjct: 148 ELLSPGSVDPLTRLVLVNAVYFRGNWDEQFDKENTEERLFKVSKNEEKPVQMMFKQSTFK 207
Query: 194 KTHYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLP 253
KT+ F +IL LPY + +M I LPD + L + +L+ E +L
Sbjct: 208 KTYIGEIFT--QILVLPYV-----GKELNMIIMLPDETTDLRTVEKELTYEKFVEWTRLD 260
Query: 254 RRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESI 313
+ +P+F + +++ +VL+ +G+ F A F+ M + +L + +
Sbjct: 261 MMDEEEVEVSLPRFKLEESYDMESVLRNLGMTDAFELGKADFSGMSQ-----TDLSLSKV 315
Query: 314 FHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVG 373
HK+F+EVNE+GT+A AA+ + + AR V F A+HPFLF I+ T ILF G
Sbjct: 316 VHKSFVEVNEEGTEAAAATAAIM-MMRCARF---VPRFCADHPFLFFIQHSKTNGILFCG 371
Query: 374 QVLNP 378
+ +P
Sbjct: 372 RFSSP 376
>PTI6_MOUSE (Q60854) Placental thrombin inhibitor (Protease
inhibitor 6) (PI-6)
Length = 378
Score = 117 bits (293), Expect = 5e-26
Identities = 92/305 (30%), Positives = 140/305 (45%), Gaps = 20/305 (6%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F DK+ L F+ Y A L LDF+ + +N+ + ++ I
Sbjct: 90 LRTANRLFGDKTCDLLASFKDSCLKFYEAELEELDFQGATEESRQHINTWVAKKTEDKIK 149
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGPR-YEFPFDLLNGTSVKVPFMTIK---K 193
++L PGT+ + T L+ NA+ F+G W+ +F+ E PF + V M K K
Sbjct: 150 EVLSPGTVNSDTSLVLVNAIYFKGNWEKQFNKEHTREMPFKVSKNEEKPVQMMFKKSTFK 209
Query: 194 KTHYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSEPGFLKGKLP 253
T+ F KIL LPY +M I LPD LS + +++ E +L
Sbjct: 210 MTYIGEIFT--KILLLPYVSS-----ELNMIIMLPDEHVELSTVEKEVTYEKFIEWTRLD 262
Query: 254 RRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLCVESI 313
+ + +PKF + + ++ L ++G+ F A F+ M S L + +
Sbjct: 263 KMDEEEVEVFLPKFKLEENYNMNDALYKLGMTDAFGGR-ADFSGM----SSKQGLFLSKV 317
Query: 314 FHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTILFVG 373
HKAF+EVNE+GT+A AA+ G V P F A+HPFLF I T ILF G
Sbjct: 318 VHKAFVEVNEEGTEAAAATAGMMTVRCMRFTP----RFCADHPFLFFIHHVKTNGILFCG 373
Query: 374 QVLNP 378
+ +P
Sbjct: 374 RFSSP 378
>SPB8_HUMAN (P50452) Cytoplasmic antiproteinase 2 (CAP2) (CAP-2)
(Protease inhibitor 8) (Serpin B8)
Length = 374
Score = 114 bits (286), Expect = 3e-25
Identities = 89/309 (28%), Positives = 146/309 (46%), Gaps = 28/309 (9%)
Query: 78 LSFTNGMFVDKSVSLSYPFRLLLAYQYNASLASLDFKNRGDRVLHDVNSLIELQSNGHIT 137
L N +F +K+ F+ Y A L L F + +N + ++ G I+
Sbjct: 86 LRTANRLFGEKTCDFLPDFKEYCQKFYQAELEELSFAEDTEECRKHINDWVAEKTEGKIS 145
Query: 138 QLLPPGTITNLTRLIFANALRFQGLWKHKFDGPRYEFPFDLLNGT-----SVKVPFMTIK 192
++L GT+ LT+L+ NA+ F+G W +FD ++ +L T +V++ F K
Sbjct: 146 EVLDAGTVDPLTKLVLVNAIYFKGKWNEQFD---RKYTRGMLFKTNEEKKTVQMMFKEAK 202
Query: 193 KKTHYIRAFDAFKILRLPYKQGRDRKRRFSMCIFLPDASDGLSALVHKLSSE---PGFLK 249
K Y ++L LPY + SM I LPD + L+ + L+ E
Sbjct: 203 FKMGYADEVHT-QVLELPYVE-----EELSMVILLPDDNTDLAVVEKALTYEKFKAWTNS 256
Query: 250 GKLPRRKVRVDALQIPKFNISFTFEASNVLKEVGVVSPFSPMDACFTKMLEINSPSNNLC 309
KL + KV+V +P+ + +++ L+ +G++ F A F+ M S N+
Sbjct: 257 EKLTKSKVQV---FLPRLKLEESYDLEPFLRRLGMIDAFDEAKADFSGM----STEKNVP 309
Query: 310 VESIFHKAFIEVNEKGTKATAASVGFAPVTQSARRPGPVINFIANHPFLFLIREDFTGTI 369
+ + HK F+EVNE+GT+A AA+ V +++R F A+HPFLF IR T I
Sbjct: 310 LSKVAHKCFVEVNEEGTEAAAATA----VVRNSRCSRMEPRFCADHPFLFFIRRHKTNCI 365
Query: 370 LFVGQVLNP 378
LF G+ +P
Sbjct: 366 LFCGRFSSP 374
Database: sprot
Posted date: Nov 25, 2004 10:54 AM
Number of letters in database: 59,974,054
Number of sequences in database: 164,201
Lambda K H
0.322 0.138 0.410
Gapped
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 44,005,905
Number of Sequences: 164201
Number of extensions: 1793711
Number of successful extensions: 4528
Number of sequences better than 10.0: 155
Number of HSP's better than 10.0 without gapping: 106
Number of HSP's successfully gapped in prelim test: 49
Number of HSP's that attempted gapping in prelim test: 4099
Number of HSP's gapped (non-prelim): 162
length of query: 381
length of database: 59,974,054
effective HSP length: 112
effective length of query: 269
effective length of database: 41,583,542
effective search space: 11185972798
effective search space used: 11185972798
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 67 (30.4 bits)
Lotus: description of TM0348.13